chr12-10825616-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_023921.2(TAS2R10):āc.654C>Gā(p.Asn218Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,613,794 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_023921.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAS2R10 | NM_023921.2 | c.654C>G | p.Asn218Lys | missense_variant | 1/1 | ENST00000240619.3 | NP_076410.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAS2R10 | ENST00000240619.3 | c.654C>G | p.Asn218Lys | missense_variant | 1/1 | 6 | NM_023921.2 | ENSP00000240619.2 | ||
PRH1 | ENST00000538332.2 | c.*19-423C>G | intron_variant | 5 | ENSP00000481761.1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 151994Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 250922Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135624
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461682Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 727140
GnomAD4 genome AF: 0.000112 AC: 17AN: 152112Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74376
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 27, 2024 | The c.654C>G (p.N218K) alteration is located in exon 1 (coding exon 1) of the TAS2R10 gene. This alteration results from a C to G substitution at nucleotide position 654, causing the asparagine (N) at amino acid position 218 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at